Fineline Cube

Follow:
14499 Articles
Insilico Medicine Files for IPO to Leverage AI in Drug Discovery
CompanyDeals

Insilico Medicine Files for IPO to Leverage AI in Drug Discovery

Pfizer's Zavicefta Approved by China's NMPA for Severe Infections in All Ages
CompanyDrug

Pfizer’s Zavicefta Approved by China’s NMPA for Severe Infections in All Ages

Amgen's Tepezza Approved in UK for Thyroid Eye Disease Treatment
CompanyDrug

Amgen’s Tepezza Approved in UK for Thyroid Eye Disease Treatment

Guangzhou Regen Therapeutics Raises RMB 100 Million in Pre-Series A Financing
CompanyDeals

Guangzhou Regenverse Therapeutics Raises RMB 100 Million in Pre-Series A Financing

Novo Nordisk Reports 18% YOY Revenue Growth in Q1 2025
Company

Novo Nordisk Reports 18% YOY Revenue Growth in Q1 2025

Sino Biopharmaceutical and JD Healthcare Forge Comprehensive Strategic Partnership
CompanyDeals

Sino Biopharmaceutical and JD Healthcare Forge Comprehensive Strategic Partnership

Adicon Holdings Acquires Suzhou Youqin Medical Laboratory and Yuande Weikang
CompanyDeals

Adicon Holdings Acquires Suzhou Youqin Medical Laboratory and Yuande Weikang

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies
CompanyDeals

Oricell Partners with Umoja Biopharma to Develop In Vivo CAR-T Cell Therapies

BeiGene's Q1 2025 Revenues Soar 49% YOY, Driven by Brukinsa Global Sales
Company

BeiGene’s Q1 2025 Revenues Soar 49% YOY, Driven by Brukinsa Global Sales

European Commission Approves J&J's Tremfya for Crohn's Disease Treatment
CompanyDrug

European Commission Approves J&J’s Tremfya for Crohn’s Disease Treatment

Amgen Reports 9% Revenue Growth in Q1 2025, Driven by Double-Digit Product Sales
Company

Amgen Reports 9% Revenue Growth in Q1 2025, Driven by Double-Digit Product Sales

AstraZeneca and Daiichi Sankyo Announce Positive DESTINY-Breast11 Trial Results for Enhertu
CompanyDrug

AstraZeneca and Daiichi Sankyo Announce Positive DESTINY-Breast11 Trial Results for Enhertu